Capstan Therapeutics Funding & Investors
San Diego, CA
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
capstantx.comTotal Amount Raised: $340,000,000
Capstan Therapeutics Funding Rounds
Series B
$175,000,000
Series B Investors
RA Capital ManagementForbion Capital PartnersAlexandria Venture InvestmentsOrbiMed AdvisorsVida VenturesNovartis Venture FundPfizer Venture InvestmentsLeaps by BayerPerceptive AdvisorsSofinnova VenturesJohnson InnovationPolaris PartnersEli Lilly and CompanyMubadala Capital VenturesBristol-Myers Squibb CompanySeries A
$102,000,000
Series A Investors
Pfizer Venture InvestmentsLeaps by BayerNovartis Venture FundOrbiMed AdvisorsEli Lilly and CompanyBristol-Myers Squibb CompanyVida VenturesAlexandria Venture InvestmentsRA Capital ManagementPolaris PartnersSeed
$63,000,000
Seed Investors
Novartis Venture FundOrbiMed AdvisorsVida VenturesRA Capital Management
Funding info provided by Diffbot.